Obalon Therapeutics Inc (OBLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OBLN | TMO | ISRG | EW | DXCM |
| Company | Obalon Therapeutics Inc | Thermo Fisher Scientific Inc | Intuitive Surg Inc | Edwards Lifesciences Corp | Dexcom Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 9.75 | 579.48 | 373.64 | 84.90 | 127.03 |
| High | 14.40 | 579.80 | 377.28 | 85.43 | 127.88 |
| Low | 8.84 | 565.49 | 367.39 | 83.81 | 124.61 |
| Last | 9.15 | 573.21 | 377.72 | 85.25 | 126.47 |
| Change | -0.57 | -1.78 | +6.02 | +0.95 | +0.59 |
| % Change | -5.86% | -0.31% | +1.62% | +1.13% | +0.47% |
| Volume | 8,927,233 | 645,006 | 506,247 | 997,901 | 1,191,481 |
| 20-Day Average Volume | 7,631,245 | 1,371,386 | 1,455,650 | 2,948,578 | 2,934,681 |
| Previous Close | 9.72 | 574.99 | 371.70 | 84.30 | 125.88 |
| Industry | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments | Medical Instruments |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.23 | 567.27 | 378.17 | 88.40 | 133.82 |
| 20-Day Raw Stochastic | 27.38% | 70.51% | 42.15% | 17.69% | 17.13% |
| 20-Day Relative Strength | 49.61% | 51.53% | 47.96% | 41.80% | 43.91% |
| Weighted Alpha | -38.05 | +8.66 | +25.46 | +1.39 | +9.32 |
| Today's Opinion | 40% Buy | 56% Buy | 40% Buy | 40% Buy | 40% Buy |
| Previous Opinion | 56% Buy | 72% Buy | 40% Buy | 40% Buy | 40% Buy |
| Last Month's Opinion | 16% Sell | 80% Buy | 64% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -8.68% since 06/08/21 | +0.07% since 04/25/24 | +0.93% since 04/25/24 | -3.19% since 04/25/24 | -8.47% since 04/25/24 |
| Low | 2.95 on 06/15/21 | 565.49 on 05/02/24 | 367.77 on 05/02/24 | 83.50 on 05/01/24 | 123.07 on 04/29/24 |
| High | 4.80 on 06/15/21 | 581.90 on 05/01/24 | 379.50 on 05/01/24 | 88.38 on 04/26/24 | 138.80 on 04/26/24 |
| 1-Month | |||||
| %Chg | +27.62% since 05/14/21 | +0.10% since 04/02/24 | -1.51% since 04/02/24 | -9.66% since 04/02/24 | -7.56% since 04/02/24 |
| Low | 2.26 on 05/17/21 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 83.50 on 05/01/24 | 123.07 on 04/29/24 |
| High | 4.88 on 05/24/21 | 589.93 on 04/09/24 | 393.66 on 04/05/24 | 95.07 on 04/03/24 | 141.99 on 04/09/24 |
| 3-Month | |||||
| %Chg | -16.67% since 03/15/21 | +3.68% since 02/02/24 | -1.87% since 02/02/24 | -1.03% since 02/02/24 | +4.43% since 02/02/24 |
| Low | 1.95 on 05/06/21 | 529.64 on 04/18/24 | 364.17 on 04/19/24 | 82.53 on 02/07/24 | 113.05 on 02/28/24 |
| High | 4.88 on 05/24/21 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| 6-Month | |||||
| %Chg | +98.03% since 12/15/20 | +27.83% since 11/02/23 | +35.52% since 11/02/23 | +30.02% since 11/02/23 | +34.85% since 11/02/23 |
| Low | 1.38 on 01/06/21 | 437.26 on 11/10/23 | 269.49 on 11/10/23 | 63.88 on 11/10/23 | 91.49 on 11/08/23 |
| High | 10.77 on 01/20/21 | 603.82 on 03/08/24 | 403.76 on 03/27/24 | 96.12 on 03/28/24 | 142.00 on 03/26/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 30,567 | 219,481,728 | 131,844,224 | 50,799,180 | 50,060,460 |
| Shares Outstanding, K | 10,022 | 381,714 | 354,706 | 602,600 | 397,684 |
| Annual Sales | 1,590,000 | 42,857,000,000 | 7,124,100,000 | 6,004,800,000 | 3,622,300,000 |
| Annual Net Income | -12,330,000 | 5,995,000,000 | 1,798,000,000 | 1,402,400,000 | 541,500,000 |
| Last Quarter Sales | 60,000 | 10,345,000,000 | 1,890,600,000 | 1,598,200,000 | 921,000,000 |
| Last Quarter Net Income | -1,320,000 | 1,327,000,000 | 544,900,000 | 351,900,000 | 146,400,000 |
| 60-Month Beta | -1.23 | 0.80 | 1.39 | 1.10 | 1.23 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.11 on 04/24/24 | 1.50 on 04/18/24 | 0.66 on 04/25/24 | 0.32 on 04/25/24 |
| Latest Earnings Date | 07/29/21 | 04/24/24 | 04/18/24 | 04/25/24 | 04/25/24 |
| Most Recent Dividend | N/A | 0.390 on 03/14/24 | N/A | N/A | N/A |
| Next Ex-Dividends Date | N/A | 03/14/24 | N/A | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.31 | 79.19 | 33.20 | 76.74 |